Increased fetal RhD gene in the maternal circulation in early pregnancy is associated with an increased risk of pre-eclampsia

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 112, Issue 5, 2005, Pages 584-587

  Cotter, Amanda M ^a,c   Martin, Cara M ^b   O'Leary, John J ^b   Daly, Sean F ^a  

^a Molecular Pathology Laboratory   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ARTICLE; BLOOD GROUP RHESUS SYSTEM; BLOOD SAMPLING; CASE CONTROL STUDY; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIRST TRIMESTER PREGNANCY; GENE; GENE PROBE; HIGH RISK PREGNANCY; HUMAN; PREECLAMPSIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RHD GENE;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DNA; FEMALE; HUMANS; PARITY; POLYMERASE CHAIN REACTION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; RHO(D) IMMUNE GLOBULIN; RISK FACTORS;

EID: 18744400795     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2004.00499.x     Document Type: Article

References (19)

1. Redman CWG, Sacks GP, Sargent IL. Pre-eclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499-506.
2. Holzgreve W, Ghezzi F, Di Naro E, Maymon E, Ganshirt D, Hahn S. Disturbed fetomaternal cell traffic in preeclampsia. Obstet Gynecol 1998;91:669-672.
3. Lo YM, Leung TN, Tein MS, et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999;45:184-188.
4. Zhong XY, Laivuori H, Livingston JC, et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol 2001;184:414-419.
5. Leung TN, Zhang J, Lau TK, Chan LYS, Lo YMD. Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem 2001;47:137-139.
6. Swinkels DW, de Kok JB, Hendriks JCM, Wiegerinck E, Zusterzeel PLM, Steegers EAP. Hemolysis, elevated liver enzymes and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum. Clin Chem 2002;48(4):650-653.
7. Bianchi DW, Lo YM. Fetomaternal cellular and plasma DNA trafficking: the Yin and the Yang. Ann N Y Acad Sci 2001;945:119-131.
8. Flori E, Doray B, Gautier E, et al. Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytiotrophoblastic cells. Hum Reprod 2004;19:723-724.
9. Zhong XY, Holzgreve W, Hahn S. Cell-free fetal DNA in the maternal circulation does not stem from the transplacental passage of fetal cells. Mol Hum Reprod 2002;8:864-870.
10. Hahn S, Holzgreve W. Fetal cells and cell-free fetal DNA in maternal blood: new insights into pre-eclampsia. Hum Reprod Update 2002;8(6):501-508.
11. Lo YMD, Hjelm NM, Fidler C, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:1734-1738.
12. Zhong XY, Holzgreve W, Hahn S. Detection of fetal Rhesus D and sex using fetal DNA from maternal plasma by multiplex polymerase chain reaction. Br J Obstet Gynaecol 2000;107:766-769.
13. Faas BHW, Beuling EA, Christiaens GCML, von dem Borne AEGK, van der Schoot CE. Detection of fetal RhD specific sequences in maternal plasma. Lancet 1998;352:1196.
14. Bischoff FZ, Nguyen DD, Marquez-Do D, Moise KJ, Leigh Simpson J, Elias S. Noninvasive determination of fetal RhD status using fetal DNA in maternal serum and PCR. J Soc Gynecol Invest 1999;6:64-69.
15. Finning KM, Martin PG, Soothill PW, Avent ND. Prediction of fetal D status from maternal plasma: introduction of a new non-invasive fetal RHD genotyping service. Transfusion 2002;42:1079-1085.
16. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 1993;86:703-708.
17. Daly LE, Kirke PN, Molloy AM, Weir DG, Scott JM. Folate levels and neural tube defects: implications for prevention. JAMA 1995;274:1698-1702.
18. Bianchi DW, Williams JM, Sullivan LM, Hanson FW, Klinger KW, Shuber AP. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 1997;61:822-829.
19. Lee T, LeShane ES, Messerlian GM, et al. Down syndrome and cell-free fetal DNA in archived maternal serum. Am J Obstet Gynecol 2002;187:1217-1221.